Bonum Therapeutics's last reported valuation, Nov 2022. Nothing priced has surfaced since.
- ·Watch Bonum Therapeutics: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Bonum Therapeutics funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Apr 2026 | Early Stage VC | $26.9M | ▮ | ▮ |
| Nov 2022 | Early Stage VC | $45.0M | ▮ | ▮ |
| Dec 2021 | Seed Round | $1.2M | ▮ | ▮ |
Membership and data by Private Market View
Bonum Therapeutics valuation
Bonum Therapeutics's last reported valuation was $130 million in Nov 2022. No priced round, secondary trade or fund mark has surfaced since.
How much has Bonum Therapeutics raised?
Bonum Therapeutics has raised $127 million across 3 recorded rounds since 2021. The largest was a $45 million early-stage round in Nov 2022; the most recent was a $26.9 million early-stage round in Apr 2026.
Bonum Therapeutics has filed 3 Form Ds with the SEC since 2021, most recently in Apr 2026 ($26.9 million sold to 8 investors).
How Bonum Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Bonum Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →
Frequently asked about Bonum Therapeutics
- What is Bonum Therapeutics worth?
- Bonum Therapeutics is valued at $130.0M as of Oct 2026. Bonum Therapeutics's last reported valuation, Nov 2022. Nothing priced has surfaced since.
- How much has Bonum Therapeutics raised?
- Bonum Therapeutics has raised $127.5M in total funding across 3 recorded rounds.
- When did Bonum Therapeutics last raise?
- Bonum Therapeutics last raised in Apr 2026 (Early Stage VC), raising $26.9M.